FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2016032140> ?p ?o ?g. }

• W2016032140 endingPage "96" @default.
• W2016032140 startingPage "88" @default.
• W2016032140 abstract "Ceramide-activated NAD(P)H oxidase has been reported to participate in homocysteine (Hcys)-induced abnormal metabolism of the extracellular matrix (ECM) in rat glomerular mesangial cells. However, it remains unknown whether this ceramide-redox signaling pathway contributes to glomerular injury induced by hyperhomocysteinemia (hHcys) in vivo. The present study was designed to address this question, defining the role of ceramide and activated NAD(P)H oxidase in the development of hHcys-induced glomerular injury. Uninephrectomized Sprague-Dawley rats were fed a folate-free diet for 8 weeks to produce hHcys and the de novo ceramide synthesis inhibitor myriocin or the NAD(P)H oxidase inhibitor apocynin was administrated. Rats with folate-free diet significantly increased plasma Hcys levels, renal ceramide levels, and NAD(P)H oxidase activity accompanied by marked glomerular injury. Treatment of rats with myriocin significantly reduced ceramide levels and improved glomerular injury, as shown by decreased urinary albumin excretion and reduced glomerular damage index. ECM components changed towards to normal levels with decreased tissue inhibitor of metalloproteinase-1 and increased matrix metalloproteinase-1 activity. NAD(P)H oxidase activity and Rac GTPase activity were reduced by 69 and 66%, respectively. In rats treated with apocynin, similar beneficial effects in protecting glomeruli from hHcys-induced injury were observed. These results support the view that de novo ceramide production is involved in Hcys-induced NAD(P)H oxidase activity in the kidney of hHcys rats and indicate the important role of ceramide-mediated redox signaling in hHcys-induced glomerular injury in rats." @default.
• W2016032140 created "2016-06-24" @default.
• W2016032140 creator A5001890015 @default.
• W2016032140 creator A5007770965 @default.
• W2016032140 creator A5009299574 @default.
• W2016032140 creator A5013306328 @default.
• W2016032140 creator A5018299105 @default.
• W2016032140 creator A5030424687 @default.
• W2016032140 creator A5069403305 @default.
• W2016032140 date "2006-07-01" @default.
• W2016032140 modified "2023-10-02" @default.
• W2016032140 title "Inhibition of ceramide–redox signaling pathway blocks glomerular injury in hyperhomocysteinemic rats" @default.
• W2016032140 cites W1579418022 @default.
• W2016032140 cites W1968171440 @default.
• W2016032140 cites W1972641293 @default.
• W2016032140 cites W1978048485 @default.
• W2016032140 cites W1980454471 @default.
• W2016032140 cites W1982002561 @default.
• W2016032140 cites W1993906594 @default.
• W2016032140 cites W2000155150 @default.
• W2016032140 cites W2002564316 @default.
• W2016032140 cites W2003241255 @default.
• W2016032140 cites W2007981595 @default.
• W2016032140 cites W2011478745 @default.
• W2016032140 cites W2012058446 @default.
• W2016032140 cites W2014959138 @default.
• W2016032140 cites W2027607346 @default.
• W2016032140 cites W2030418679 @default.
• W2016032140 cites W2034207232 @default.
• W2016032140 cites W2040043599 @default.
• W2016032140 cites W2052860570 @default.
• W2016032140 cites W2053854198 @default.
• W2016032140 cites W2062440171 @default.
• W2016032140 cites W2068561628 @default.
• W2016032140 cites W2076875353 @default.
• W2016032140 cites W2083386249 @default.
• W2016032140 cites W2084699108 @default.
• W2016032140 cites W2094194778 @default.
• W2016032140 cites W2100707728 @default.
• W2016032140 cites W2106334153 @default.
• W2016032140 cites W2108730399 @default.
• W2016032140 cites W2116089455 @default.
• W2016032140 cites W2140587661 @default.
• W2016032140 cites W2162537991 @default.
• W2016032140 cites W2163374884 @default.
• W2016032140 cites W2169878907 @default.
• W2016032140 cites W2170723783 @default.
• W2016032140 cites W32741228 @default.
• W2016032140 cites W4245200655 @default.
• W2016032140 cites W4247794967 @default.
• W2016032140 doi "https://doi.org/10.1038/sj.ki.5001517" @default.
• W2016032140 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16688115" @default.
• W2016032140 hasPublicationYear "2006" @default.
• W2016032140 type Work @default.
• W2016032140 sameAs 2016032140 @default.
• W2016032140 citedByCount "82" @default.
• W2016032140 countsByYear W20160321402012 @default.
• W2016032140 countsByYear W20160321402013 @default.
• W2016032140 countsByYear W20160321402014 @default.
• W2016032140 countsByYear W20160321402015 @default.
• W2016032140 countsByYear W20160321402016 @default.
• W2016032140 countsByYear W20160321402017 @default.
• W2016032140 countsByYear W20160321402019 @default.
• W2016032140 countsByYear W20160321402020 @default.
• W2016032140 countsByYear W20160321402021 @default.
• W2016032140 countsByYear W20160321402022 @default.
• W2016032140 countsByYear W20160321402023 @default.
• W2016032140 crossrefType "journal-article" @default.
• W2016032140 hasAuthorship W2016032140A5001890015 @default.
• W2016032140 hasAuthorship W2016032140A5007770965 @default.
• W2016032140 hasAuthorship W2016032140A5009299574 @default.
• W2016032140 hasAuthorship W2016032140A5013306328 @default.
• W2016032140 hasAuthorship W2016032140A5018299105 @default.
• W2016032140 hasAuthorship W2016032140A5030424687 @default.
• W2016032140 hasAuthorship W2016032140A5069403305 @default.
• W2016032140 hasBestOaLocation W20160321401 @default.
• W2016032140 hasConcept C126322002 @default.
• W2016032140 hasConcept C134018914 @default.
• W2016032140 hasConcept C181199279 @default.
• W2016032140 hasConcept C185592680 @default.
• W2016032140 hasConcept C190283241 @default.
• W2016032140 hasConcept C2776151105 @default.
• W2016032140 hasConcept C2777209548 @default.
• W2016032140 hasConcept C2777851122 @default.
• W2016032140 hasConcept C2779719074 @default.
• W2016032140 hasConcept C2781252958 @default.
• W2016032140 hasConcept C55493867 @default.
• W2016032140 hasConcept C71924100 @default.
• W2016032140 hasConcept C75520062 @default.
• W2016032140 hasConcept C86803240 @default.
• W2016032140 hasConceptScore W2016032140C126322002 @default.
• W2016032140 hasConceptScore W2016032140C134018914 @default.
• W2016032140 hasConceptScore W2016032140C181199279 @default.
• W2016032140 hasConceptScore W2016032140C185592680 @default.
• W2016032140 hasConceptScore W2016032140C190283241 @default.
• W2016032140 hasConceptScore W2016032140C2776151105 @default.
• W2016032140 hasConceptScore W2016032140C2777209548 @default.
• W2016032140 hasConceptScore W2016032140C2777851122 @default.

• next